SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is a top trending stock after receiving FDA approval for its oral Wegovy pill, a development widely regarded by the community as a significant game-changer in the weight-loss market. Investors are keenly discussing the pill's potential advantages over injectable treatments and its impact on NVO's valuation compared to competitors like Eli Lilly, though some 'sell the news' sentiment is also present.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Crypto is trending with its passionate community rallying around the "OG meme" status and active efforts to expand the Rage Comics lore, including RageGames tournaments and the revival of ragemaker.net. Investors express strong conviction that the project is undervalued, aiming to onboard a million users and positioning itself for significant growth within the broader crypto market.

Starfighters Space Inc

Starfighters Space (FJET), a recent aerospace IPO utilizing F-104 jets for satellite launches, is experiencing extreme volatility and trending due to its low float and association with the currently hot space sector. The community is actively debating its "parabolic moves" and potential for massive gains, drawing comparisons to other high-flying stocks, though significant concerns about its early-stage business model and "pump and dump" risks are also widely discussed.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2025 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is actively trending amidst significant acquisition speculation, driven by reports that Apollo-backed Legendary is weighing a takeover. The community is buzzing with discussions about various potential suitors, including major streaming players, recognizing Lionsgate's valuable film and television library as a key asset in the ongoing media consolidation landscape.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as Oracle founder Larry Ellison has personally guaranteed over $40 billion in equity financing for its all-cash offer to acquire Warner Bros. Discovery, directly addressing prior financial certainty concerns. This significantly strengthens PSKY's bid, with the community actively debating whether WBD's board can continue to favor Netflix's offer amidst mounting regulatory scrutiny and perceived shareholder disadvantages. The move reshapes the ongoing media industry battle, with many seeing PSKY's proposal as a now-superior path for WBD shareholders.

TOSHI

TOSHI is actively discussed as community members seize recent pullbacks as prime accumulation opportunities, reinforcing strong conviction in its long-term potential as the "Face of Base." Amid chatter regarding new exchange listings and upcoming utility projects like Toshi Mobile, many anticipate a significant upward move for the "blue cat," considering it currently oversold.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent drill results indicating significant high-grade silver in its Vortex system, fueling strong community discussion about its long-term potential. Amid a favorable environment for precious metals, the stock is drawing fervent bullish sentiment, notably from those tracking substantial institutional investments, though some express skepticism regarding its operational readiness and short-term volatility.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending intensely as the community reacts to Novo Nordisk's recent oral GLP-1 FDA approval, largely perceiving it as a significant de-risking event for the broader oral weight-loss market. Investors are actively comparing VKTX's VK2735 oral and injectable programs against new data from rivals like Eli Lilly, highlighting its potential for best-in-class efficacy with a more favorable tolerability profile amidst discussions of competitor side effects. This dynamic, coupled with anticipation around VKTX's oral VK2735 FDA meeting and the upcoming J.P. Morgan conference, is fueling widespread speculation about major partnerships or an acquisition.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending due to renewed confidence in its AI Platform (AIP), driven by accelerating commercial adoption and continued integration into government defense programs, including new shipbuilding and drone initiatives. The community is actively celebrating strong performance, with many noting bullish technicals and significant discussion around short positions facing pressure, solidifying its perception as a leading AI and data analytics provider.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending intensely amid its recent S&P 500 inclusion, which has fueled anticipation of sustained upside from forced institutional buying and recent analyst upgrades. However, a significant portion of the community is actively debating the stock's severe overvaluation and the potential for a sharp correction, citing ongoing concerns about its subprime lending practices and the broader used car market outlook. Sentiment remains deeply divided on whether current valuations are sustainable post-inclusion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Hold" from Analysts

Bausch Health Cos Inc. (NYSE:BHC - Get Free Report) has received a consensus rating of "Hold" from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five...

Bausch Health Companies (TSE:BHC) Raised to "Hold" at Raymond James Financial

Raymond James Financial upgraded Bausch Health Companies to a "hold" rating in a report on Monday...

Bausch Health Cos (NYSE:BHC) Raised to Hold at Raymond James Financial

Raymond James Financial upgraded Bausch Health Cos to a "hold" rating in a report on Monday...

Nomura Holdings Inc. Sells 1,900,000 Shares of Bausch Health Cos Inc. $BHC

Nomura Holdings Inc. decreased its position in Bausch Health Cos Inc. (NYSE:BHC - Free Report) by 8.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...

Bausch Health Cos Inc. $BHC Stock Holdings Lifted by Paulson & CO. Inc.

Paulson & CO. Inc. boosted its holdings in shares of Bausch Health Cos Inc. (NYSE:BHC - Free Report) by 24.0% during the 2nd quarter, according to its most recent filing with the Securities and...

Bausch Health's Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake

Key PointsLombard Odier Asset Management (USA) Corp sold 3,334,000 shares of Bausch Health Companies; position value declined by approximately $22,564,800...

Bausch Health Cos (NYSE:BHC) Raised to "Hold" at Barclays

Barclays upgraded shares of Bausch Health Cos to a "hold" rating in a research report on Monday...

Bausch Health Cos Inc. $BHC is Goldentree Asset Management LP's Largest Position

Goldentree Asset Management LP increased its position in shares of Bausch Health Cos Inc. (NYSE:BHC - Free Report) by 13.2% during the second quarter, according to its most recent Form 13F filing...

BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution Business 

BHC jumps 11% as Solta Medical acquires Wuhan Shibo Zhenmei, gaining full control of its China aesthetics distribution business.

Bausch Health Cos (NYSE:BHC) Shares Gap Up - Here's Why

Bausch Health Cos (NYSE:BHC) Shares Gap Up - Here's What Happened...

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

BHC
Bausch Health Companies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BHC News

BHCBausch Health Companies Inc